Douglas Earl Martin

Avg. Two Year Performance

(17%) Avg. Purchase Return
(8%) Compound
41% Avg. Sale Return
19% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(10%)(25%)(8%)(44%)(17%)
Purchase Success Rate1 of 21 of 21 of 20 of 21 of 2
Average Sale Return(6%)(5%)(18%)(16%)41%
Sale Success Rate0 of 52 of 53 of 51 of 52 of 5

BioMimetic Therapeutics Inc.

Health Services » Medical Instruments & Supplies

General Counsel:

Holdings: 11.06K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Allogene Therapeutics, Inc.

Other » Other

SVP, General Counsel:

Holdings: 477.63K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--